NexImmune, Inc.
NEXI
$0.0001
$0.000.00%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 57.71% | 54.68% | 48.25% | 28.23% | 20.15% |
| Total Depreciation and Amortization | -35.20% | -15.08% | 3.03% | 8.89% | 11.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -36.69% | -18.80% | -25.41% | -24.59% | -6.49% |
| Change in Net Operating Assets | -190.86% | -132.98% | -224.15% | -44.71% | -78.75% |
| Cash from Operations | 57.38% | 54.12% | 38.60% | 28.70% | 16.07% |
| Capital Expenditure | 99.88% | 99.37% | 96.12% | 82.37% | 29.54% |
| Sale of Property, Plant, and Equipment | 605.94% | 551.98% | -94.80% | 17,100.00% | 16,260.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -100.00% | -52.86% |
| Cash from Investing | -95.15% | -98.69% | -100.09% | -100.34% | -53.63% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -38.90% | -38.90% | -- | -100.00% | 585.14% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -38.90% | -38.90% | -- | -100.00% | 585.32% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 43.10% | -713.30% | -831.38% | -527.13% | -5.53% |
